These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump. Fedorova OV; Kashkin VA; Zakharova IO; Lakatta EG; Bagrov AY J Hypertens; 2012 Sep; 30(9):1817-26. PubMed ID: 22796708 [TBL] [Abstract][Full Text] [Related]
29. Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling. Haller ST; Yan Y; Drummond CA; Xie J; Tian J; Kennedy DJ; Shilova VY; Xie Z; Liu J; Cooper CJ; Malhotra D; Shapiro JI; Fedorova OV; Bagrov AY J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694325 [TBL] [Abstract][Full Text] [Related]
30. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats. Arvola P; Ruskoaho H; Pörsti I Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Haller ST; Kennedy DJ; Shidyak A; Budny GV; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY Am J Hypertens; 2012 Jun; 25(6):690-6. PubMed ID: 22378033 [TBL] [Abstract][Full Text] [Related]